Literature DB >> 28460414

CRISPR Editing Technology in Biological and Biomedical Investigation.

Martyn K White1, Rafal Kaminski1, Won-Bin Young1, Pamela C Roehm1, Kamel Khalili1.   

Abstract

The CRISPR or clustered regularly interspaced short palindromic repeats system is currently the most advanced approach to genome editing and is notable for providing an unprecedented degree of specificity, effectiveness, and versatility in genetic manipulation. CRISPR evolved as a prokaryotic immune system to provide an acquired immunity and resistance to foreign genetic elements such as bacteriophages. It has recently been developed into a tool for the specific targeting of nucleotide sequences within complex eukaryotic genomes for the purpose of genetic manipulation. The power of CRISPR lies in its simplicity and ease of use, its flexibility to be targeted to any given nucleotide sequence by the choice of an easily synthesized guide RNA, and its ready ability to continue to undergo technical improvements. Applications for CRISPR are numerous including creation of novel transgenic cell animals for research, high-throughput screening of gene function, potential clinical gene therapy, and nongene-editing approaches such as modulating gene activity and fluorescent tagging. In this prospect article, we will describe the salient features of the CRISPR system with an emphasis on important drawbacks and considerations with respect to eliminating off-target events and obtaining efficient CRISPR delivery. We will discuss recent technical developments to the system and we will illustrate some of the most recent applications with an emphasis on approaches to eliminate human viruses including HIV-1, JCV and HSV-1 and prospects for the future. J. Cell. Biochem. 118: 3586-3594, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CRISPR; Cas9; GENOME EDITING

Mesh:

Year:  2017        PMID: 28460414      PMCID: PMC5682924          DOI: 10.1002/jcb.26099

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  83 in total

1.  Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.

Authors:  Ming Wang; John A Zuris; Fantao Meng; Holly Rees; Shuo Sun; Pu Deng; Yong Han; Xue Gao; Dimitra Pouli; Qi Wu; Irene Georgakoudi; David R Liu; Qiaobing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 2.  TALEN-mediated genome editing: prospects and perspectives.

Authors:  David A Wright; Ting Li; Bing Yang; Martin H Spalding
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

Review 3.  High-throughput functional genomics using CRISPR-Cas9.

Authors:  Ophir Shalem; Neville E Sanjana; Feng Zhang
Journal:  Nat Rev Genet       Date:  2015-04-09       Impact factor: 53.242

Review 4.  Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.

Authors:  Shengdar Q Tsai; J Keith Joung
Journal:  Nat Rev Genet       Date:  2016-05       Impact factor: 53.242

5.  Structure and Engineering of Francisella novicida Cas9.

Authors:  Hisato Hirano; Jonathan S Gootenberg; Takuro Horii; Omar O Abudayyeh; Mika Kimura; Patrick D Hsu; Takanori Nakane; Ryuichiro Ishitani; Izuho Hatada; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

6.  Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.

Authors:  Keiji Nishida; Takayuki Arazoe; Nozomu Yachie; Satomi Banno; Mika Kakimoto; Mayura Tabata; Masao Mochizuki; Aya Miyabe; Michihiro Araki; Kiyotaka Y Hara; Zenpei Shimatani; Akihiko Kondo
Journal:  Science       Date:  2016-08-04       Impact factor: 47.728

7.  Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system.

Authors:  Baohui Chen; Luke A Gilbert; Beth A Cimini; Joerg Schnitzbauer; Wei Zhang; Gene-Wei Li; Jason Park; Elizabeth H Blackburn; Jonathan S Weissman; Lei S Qi; Bo Huang
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

Review 8.  Using CRISPR/Cas to study gene function and model disease in vivo.

Authors:  Darjus F Tschaharganeh; Scott W Lowe; Ralph J Garippa; Geulah Livshits
Journal:  FEBS J       Date:  2016-06-16       Impact factor: 5.542

9.  CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.

Authors:  Gang Wang; Na Zhao; Ben Berkhout; Atze T Das
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

10.  CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.

Authors:  Ferdy R van Diemen; Elisabeth M Kruse; Marjolein J G Hooykaas; Carlijn E Bruggeling; Anita C Schürch; Petra M van Ham; Saskia M Imhof; Monique Nijhuis; Emmanuel J H J Wiertz; Robert Jan Lebbink
Journal:  PLoS Pathog       Date:  2016-06-30       Impact factor: 6.823

View more
  8 in total

Review 1.  Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies.

Authors:  Tram M Ta; Sajjaf Malik; Elizabeth M Anderson; Amber D Jones; Jocelyn Perchik; Maryann Freylikh; Luca Sardo; Zackary A Klase; Taisuke Izumi
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 6.064

Review 2.  Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique.

Authors:  Michele Marangi; Giuseppa Pistritto
Journal:  Front Pharmacol       Date:  2018-04-20       Impact factor: 5.810

3.  CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.

Authors:  Xiao-Rui Luan; Xiao-Ling Chen; Yue-Xiao Tang; Jin-Yan Zhang; Xiang Gao; Hai-Ping Ke; Zhao-Yu Lin; Xian-Ning Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-02       Impact factor: 8.886

Review 4.  Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection.

Authors:  Tetsuo Tsukamoto
Journal:  Pharmaceutics       Date:  2019-03-11       Impact factor: 6.321

5.  Gene editing and elimination of latent herpes simplex virus in vivo.

Authors:  Martine Aubert; Daniel E Strongin; Pavitra Roychoudhury; Michelle A Loprieno; Anoria K Haick; Lindsay M Klouser; Laurence Stensland; Meei-Li Huang; Negar Makhsous; Alexander Tait; Harshana S De Silva Feelixge; Roman Galetto; Philippe Duchateau; Alexander L Greninger; Daniel Stone; Keith R Jerome
Journal:  Nat Commun       Date:  2020-08-18       Impact factor: 17.694

6.  Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment.

Authors:  Charles E Lewis; Bradley Pickering
Journal:  ILAR J       Date:  2022-01-07

Review 7.  GM insect pests under the Brazilian regulatory framework: development and perspectives.

Authors:  Paulo P Andrade; Marília Andreza da Silva Ferreira; Marta Silva Muniz; Amaro de Casto Lira-Neto
Journal:  BMC Proc       Date:  2018-07-19

8.  Study of Photochemical Cytosine to Uracil Transition via Ultrafast Photo-Cross-Linking Using Vinylcarbazole Derivatives in Duplex DNA.

Authors:  Siddhant Sethi; Shigetaka Nakamura; Kenzo Fujimoto
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.